Pharma IQ Members

Market Access

Find out everything you need to know about the latest pricing, reimbursement and market access strategies that will drive your business development.

215 results
of 20
Contributor: Pharma IQ
Posted: 11/07/2017
Pharma IQ
Despite some in the market choosing to shut down certain departments, many in the pharma industry are embarking on expansions. Ireland is expected to see a lot of growth Full Content »
Contributor: Pharma IQ News
Posted: 20/06/2017
Pharma IQ News
The Reputation Institute has revealed the top 10 most reputable pharma companies as voted by the general public. In a surprising result, AstraZeneca and GSK both failed to make the top 10. Full Content »
Contributor: Chanice Henry
Posted: 13/06/2017
Chan
Astrazeneca and its biologics arm, Medimmune, advance in the R&D race as three new oncology drug candidates see promising developments Full Content »
Contributor: Pharma IQ
Posted: 09/05/2017
Pharma IQ
Pharma IQ explores the power behind medicine optimisation and the trends emerging in the pharma and healthcare market recently. Full Content »
Contributor: Ash Rishi
Posted: 18/04/2017
Ash Rishi
Patient education is an important factor in disease self-management, and when handled properly it has been found to have a significant, positive impact on improving patient outcomes. Full Content »
Contributor: Pharma IQ
Posted: 11/04/2017
Pharma IQ
The International Society of Cellular Therapy (ISCT) has decided to speak out regarding oncoming health budget cuts in the US due to fears of the consequences for science, clinical care and patients in the US and internationally. T Full Content »
Contributor: Pharma IQ News
Posted: 27/03/2017
Pharma IQ News
Labelled as one of the globe’s fastest growing pharmaceutical markets, Russia’s medicinal industry is set to rise from 2016’s value of $20.91 billion in 2016 to $38.56 billion by 2021, representing a compound annual growth rate of 13%, according to research firm GlobalData. Full Content »
Contributor: Pharma IQ
Posted: 14/03/2017
Pharma IQ
Experts have forecasted that the French pharmaceutical market is heading for a period of stagnation, with the market value set to shrink by $1billion over the next four years. Full Content »
Contributor: Ash Rishi
Posted: 07/02/2017
Ash Rishi
When it comes to manoeuvrability and nimble response, large companies have more in common with ocean liners than speedboats. Policies are agreed, marketing strategies planned, and future developments or projects set in motion months or years in advance. Full Content »
Posted: 06/02/2017
Pharma IQ
One healthcare official told me yesterday, 'Yes, drug prices need to come down. At the same time, though, we do need to ensure that pharma companies do keep the incentive to innovate.' And I've got the boss of one of the biggest healthcare companies in the world sitting right next to me, that's Joe Jimenez the CEO of Novartis. Full Content »
Contributor: Dr Steven Bradshaw
Posted: 13/01/2017
Dr Steven Bradshaw
At the start of 2016, the industry predicted many market access trends. As we come to the end of the year, let us look at the market access trends predicted at the start of 2016. How have these predictions unfolded so far and what will be the next set of trends for the coming year? Full Content »
215 results
of 20